Vial

FEBRUARY 29, 2024

Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsor companies. billion, projected to grow at a compound annual growth rate (CAGR) of 6.9% between 2023 and 2032.

Clinical Trials 52

Clinical Trials Trials Clinical Research Marketing 52

Perficient: Drug Development

AUGUST 12, 2023

This is what everyone is talking about in the market, and I couldn’t be more excited to learn not just about Salesforce AI capabilities, but how we can understand and trust AI more effectively. The AI market is projected to reach $407B by 2027, which is substantial growth from its $86.9B in revenue in 2022.

Marketing 52

Marketing 52

Drug Discovery World

AUGUST 3, 2023

For example, the FDA has not approved a marketing application for cannabis for the treatment of any disease or condition to date 1. There is, however, one cannabis-derived drug product that the FDA has approved, which is Epidiolex (cannabidiol).

Clinical Trials 130

Clinical Trials Regulations Production FDA 130

Drug Discovery World

NOVEMBER 17, 2022

SkyQuest Technology recently released a report: Global Synthetic Biology Market Insights, which highlights the sector’s value and potential. It shows that the synthetic biology market was valued at US$9.5 billion by 2027. . These factors can significantly contribute to the growth of the synthetic biology market, it adds. .

Engineering 130

Engineering Molecular Biology Synthetic Chemistry DNA 130

Agency IQ

MAY 17, 2024

How have pre-submission meetings for generic drug applicants changed under GDUFA III? Under GDUFA III, the scope and purpose of pre-submission meetings for generic drug developers has changed. The generic drug user fee program is currently on its third iteration (i.e.,

Science 40

Science FDA Production Drugs 40

Drug Discovery World

JANUARY 11, 2023

Part of a set of emerging therapies with novel mechanisms of action, it will contribute to the growing market share held by these therapies. . Pegcetacoplan (EMPAVELI/ASPAVELI/APL-2) developed by Apellis Pharmaceuticals Inc. The report. Read the report in full. .

Drugs 130

Drugs Trials Pharmaceuticals Treatment 130

Drug Discovery World

NOVEMBER 15, 2022

Synthetic libraries for antibody drug discovery . Developing therapeutic antibodies, one of the most successful approaches in drug development, involves identifying and characterising antibodies to be used as treatment against different types of cancers as well as autoimmune and cardiovascular diseases.

DNA 246

DNA Engineering Drugs Vaccine 246